Health Care Costs

"Health Care Costs" Main

Latest Morning Briefing Stories

蘑菇影院 Health News' 'What the Health?': Biden Wins Early Court Test for Medicare Drug Negotiations

Podcast

A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration鈥檚 Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join 蘑菇影院 Health News鈥 Julie Rovner to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.

The No Surprises Act Comes With Some Surprises

蘑菇影院 Health News Original

The No Surprises Act, the landmark law intended to protect patients from surprise out-of-network medical bills, has come with, well, some surprises. A little more than two years after it took effect, there鈥檚 good and bad news about how it鈥檚 working. First, it鈥檚 important to note that the law has successfully protected millions of patients […]

For the Love of Health Care and Health Policy

蘑菇影院 Health News Original

蘑菇影院 Health News shares the cr猫me de la cr猫me of reader-submitted health policy valentines. Two of our favorites melted our hearts and inspired original illustrations.

Halfway Through 鈥楿nwinding,鈥 Medicaid Enrollment Is Down About 10 Million

蘑菇影院 Health News Original

We鈥檙e halfway through the Medicaid 鈥渦nwinding,鈥 in which states are dropping people from the government health insurance program for the first time since the pandemic began. Millions of people have been dumped from the rolls since April, often for procedural issues like failing to respond to notices or return paperwork. But at the same time, […]

蘑菇影院 Health News' 'What the Health?': The Struggle Over Who Gets the Last Word

Podcast

As science skepticism pervades politics, the Supreme Court will soon consider two cases that seek to define the power of 鈥渆xperts.鈥 Meanwhile, abortion opponents are laying out plans for how Donald Trump, if reelected as president, could effectively curtail abortion even in states where it remains legal. Sandhya Raman of CQ Roll Call, Joanne Kenen of Johns Hopkins University and Politico Magazine, and Sarah Karlin-Smith of the Pink Sheet join 蘑菇影院 Health News鈥 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Samantha Liss, who reported and wrote the latest 蘑菇影院 Health News-NPR 鈥淏ill of the Month鈥 feature about a husband and wife who got billed for preventive care that should have been fully covered.

蘑菇影院 Health News' 'What the Health?': Health Enters the Presidential Race

Podcast

New Hampshire voters have spoken, and it seems increasingly clear that this November鈥檚 election will pit President Joe Biden against former President Donald Trump. Both appear to be making health a key part of their campaigns, with Trump vowing (again) to repeal the Affordable Care Act, and Biden stressing his support for contraception and abortion rights. Meanwhile, both candidates will try to highlight efforts to rein in prescription drug prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Jessie Hellmann of CQ Roll Call join 蘑菇影院 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Sarah Somers of the National Health Law Program about the potential consequences for the health care system if the Supreme Court overturns a key precedent attempting to balance executive vs. judicial power.

The FTC Escalates Biden鈥檚 Fight Against Drug Prices

蘑菇影院 Health News Original

It鈥檚 daggers out at the Federal Trade Commission in its fight against anticompetitive practices in health care. This past year, it has issued more stringent guidelines to block and discourage hospital mergers, and it investigated practices by middlemen in the drug supply chain. Now drug manufacturers themselves are in the agency鈥檚 crosshairs. In November, the FTC challenged the validity of more […]